Laurie Keating is CLO & VP at ALNYLAM PHARMACEUTICALS, INC. (ALNY). They have made 19 open-market trades across 4 companies since 2017, most recently 2022-05-16.
CIK 0001620743
4 open-market purchases totalling $1.7M since 2017, against 15 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IMRX | BUY | 2022-05-16 | 2022-05-17 | $5.00 | $35K | -6.5% | -11.3% | +33.8% |
| PEPG | BUY | 2022-05-06 | 2023-01-19 | $12.00 | $50K | -5.1% | +1.0% | -24.0% |
| ALNY | SELL | 2021-08-05 | 2021-08-09 | $188.95 | $1.9M | -2.5% | -7.7% | -6.9% |
| IMRX | BUY | 2021-08-03 | 2021-08-04 | $15.00 | $105K | +30.0% | +22.9% | +25.8% |
| ALNY | SELL | 2021-07-12 | 2021-07-14 | $178.96 | $1.2M | +4.7% | +15.6% | +19.6% |
| ALNY | SELL | 2021-06-09 | 2021-06-11 | $154.00 | $267K | +5.6% | +7.0% | +14.6% |
| ALNY | SELL | 2021-01-13 | 2021-01-15 | $169.90 | $1.5M | -7.8% | -8.4% | -17.2% |
| ALNY | SELL | 2021-01-11 | 2021-01-13 | $159.91 | $2.5M | +0.1% | -7.0% | -19.8% |
| ALNY | SELL | 2020-07-13 | 2020-07-14 | $160.67 | $15.2M | -2.8% | -12.7% | -6.7% |
| ALNY | SELL | 2020-04-20 | 2020-04-22 | $139.00 | $1.4M | -2.3% | +0.5% | +13.0% |
| ALNY | SELL | 2020-02-10 | 2020-02-12 | $129.00 | $1.3M | -11.0% | -24.2% | +7.6% |
| ALNY | SELL | 2020-01-29 | 2020-01-31 | $119.00 | $754K | +15.6% | -1.0% | +13.6% |
| ALNY | SELL | 2020-01-27 | 2020-01-29 | $117.69 | $9.2M | +12.7% | +0.8% | +17.8% |
| ALNY | SELL | 2018-06-20 | 2018-06-22 | $105.04 | $328K | -5.2% | +2.2% | -8.0% |
| ALNY | SELL | 2018-03-20 | 2018-03-22 | $149.36 | $302K | -27.7% | -32.3% | -25.6% |
| ALNY | SELL | 2018-03-12 | 2018-03-14 | $145.00 | $2.9M | -2.9% | -29.4% | -25.8% |
| ALKS | SELL | 2017-12-20 | 2017-12-21 | $121.07 | $1.2M | +3.6% | +9.4% | +14.9% |
| ALNY | SELL | 2017-12-01 | 2017-12-05 | $135.99 | $5.4M | -1.6% | +3.4% | -0.8% |
| ALNY | BUY | 2017-05-30 | 2017-05-31 | $65.35 | $1.5M | +10.1% | +20.6% | +24.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.